Could a nasal spray tame PTSD? new trial investigates
NCT ID NCT04044534
First seen Oct 31, 2025 · Last updated Apr 30, 2026 · Updated 12 times
Summary
This small phase 2 study tests whether insulin delivered as a nasal spray can reduce PTSD symptoms in 20 adults aged 21-65 with current PTSD. Participants receive the spray and are monitored for changes in symptom severity. The goal is to see if this approach offers a new way to ease PTSD without major side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Connecticut Healthcare System
RECRUITINGWest Haven, Connecticut, 06516, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.